Provided by Tiger Fintech (Singapore) Pte. Ltd.

JACOBIO-B

10.200
-0.390-3.68%
Volume:10.09M
Turnover:102.41M
Market Cap:8.05B
PE:-46.49
High:10.720
Open:10.590
Low:9.860
Close:10.590
52wk High:11.800
52wk Low:1.200
Shares:789.00M
HK Float Shares:789.00M
Volume Ratio:0.81
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.219
ROE:-5.15%
ROA:-3.66%
PB:8.50
PE(LYR):-46.49
PS:36.60

Loading ...

Company Profile

Company Name:
JACOBIO-B
Exchange:
SEHK
Establishment Date:
2015
Employees:
211
Office Location:
Building 8,No.105 Jinghai 3rd Road,Beijing Economic-Technological Development Area,Beijing,China
Zip Code:
- -
Fax:
- -
Introduction:
Jacobio Pharmaceuticals Group Co Ltd is an investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-21822 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly operates its businesses in China market.

Directors

Name
Position
WANG Yin Xiang
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
WANG Xiao Jie
Executive Director,Member of the Remuneration and Assessment Committee
HU Yun Yan
Executive Director,Member of the Nomination Committee
SONG Rui Lin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
WU Ge
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LU Bai
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
CHEN De Li
Director,Member of the Remuneration and Assessment Committee,Audit Committee Member

Shareholders

Name
Position
WANG Yin Xiang
CEO
WANG Xiao Jie
CEO
HU Yun Yan
Vice General Manager
XUE Qing
Corporate Secretary
ZHONG Ming Hui
Corporate Secretary
WANG Yi
Other Senior Executives,Other Senior Executives